Passage BIO, Inc. (PASG) [Rocket]

In millions, except per share items	Jun-30-23	Mar-31-23	Dec-31-22	Sep-30-22	Jun-30-22	Mar-31-22	Sep-30-21	Jun-30-21
	10-Q	10-Q	10-K	10-Q	10-Q	10-Q	10-Q	10-Q
Operating expenses:
Research and development	67.2	76.7	86.1				84.7	78.9
General and administrative	48.4	53.3	49.3				53.0	45.8
Loss from operations	-117.0	-131.5	-138.4				-173.6	-155.2
Other income (expense), net	3.1	1.8
Net loss	-112.0	-127.7	-136.1				-173.2	-154.8

Per share information:
Net loss per share of common stock, basic	($2.05)	($2.34)	($2.50)				($3.38)	($3.14)
Net loss per share of common stock, diluted	($2.05)	($2.34)	($2.50)				($3.38)	($3.14)

Weighted average common shares outstanding, basic	54.6	54.5	54.4				51.2	49.1
Weighted average common shares outstanding, diluted	54.6	54.5	54.4				39.8	26.3

Comprehensive loss:
Net loss	-112.0	-127.7	-136.1				-173.2	-154.8
Unrealized gain (loss) on marketable securities	1.2	0.9	-0.6
Comprehensive loss	-110.7	-126.7	-136.7				-173.1	-154.8